Nutex Health Gross Profit

Nutex Health posts a gross profit of $430M as of June 2026. That compares with $22B in the prior-year period — down 98.1% year over year. That is below the Consumer Staples sector average of $62B. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Nutex Health's gross profit was $22B. The latest reading is $430M — a 98.1% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Consumer Staples stocks, a gross profit near $62B is typical. Nutex Health's $430M is lower that level. That is roughly 99.3% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Gross Profit is one piece of Nutex Health's financial statement story. At $430M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for NUTX's gross profit usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $62B), and (3) consistency with growth and profitability. This page covers the first two; Nutex Health's other metric pages and overview cover the third.